Is telehealth allowed to prescribe Mounjaro in Pennsylvania?

If you’ve been considering GLP-1 medications like Wegovy, Ozempic, or Mounjaro for weight loss, you might be wondering: Can I actually get these medications through telehealth? The short answer is yes—and for many people, it’s become the most convenient and accessible way to access evidence-based obesity treatment.

In this comprehensive guide, we’ll walk you through everything you need to know about getting weight loss medication through telehealth in 2025, including federal and state regulations, what to expect during your virtual consultation, and how to ensure you’re working with a legitimate provider.

Understanding Telehealth for Weight Loss: The Legal Landscape

Federal Law Is Clear: GLP-1 Medications Can Be Prescribed via Telehealth

Here’s an important fact that clears up a lot of confusion: GLP-1 weight loss medications are not controlled substances. This means they’re not subject to the Ryan Haight Act, which requires an in-person visit before prescribing certain controlled medications like Adderall or opioids.

Since medications like Wegovy (semaglutide), Ozempic (semaglutide), and Mounjaro (tirzepatide) are non-controlled drugs, federal law places no restrictions on prescribing them via telehealth. A licensed healthcare provider can evaluate you through a video consultation and electronically send your prescription to a pharmacy—no in-person visit required under federal regulations.

During the COVID-19 pandemic, the DEA temporarily waived in-person requirements even for controlled substances to expand telehealth access. Those flexibilities have been extended through December 31, 2025, but this primarily affects medications like ADHD stimulants and certain pain medications—not the GLP-1 drugs used for weight loss.

State Regulations: Where Things Get More Nuanced

While federal law gives telehealth providers the green light, individual states have their own medical practice laws that can add requirements. Most states fully support telehealth prescribing for weight loss medications, but some require additional steps:

States Requiring an Initial In-Person Exam:

• Arkansas, Delaware, Georgia, Mississippi, New Jersey, North Dakota, South Carolina, Texas, and Virginia require (or strongly recommend) an initial in-person physical examination before prescribing weight loss medications via telehealth.

States with Additional Requirements:

• Florida mandates that patients have a BMI of 30 or higher and be seen at least once every three months during treatment.
• Connecticut requires behavioral counseling and a documented diet/exercise plan alongside medication.
• New Jersey and Virginia require comprehensive initial evaluations including lab work, physical exam, and a personalized lifestyle plan.

States with No Special Restrictions:California, Illinois, New York, Pennsylvania, Washington, and Utah allow telehealth prescribing without mandating in-person visits, as long as the provider establishes an appropriate patient-provider relationship via live video consultation.

The good news? No state outright bans telehealth for these medications. The variations are about meeting each state’s standard of care—and reputable telehealth providers like Klarity Health ensure compliance with your state’s specific requirements.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Who Can Prescribe Weight Loss Medications via Telehealth?

Physicians (MDs and DOs)

All states allow licensed physicians to prescribe GLP-1 medications through telehealth, provided they’re licensed in the state where you’re physically located during the consultation.

Nurse Practitioners (NPs) and Physician Assistants (PAs)

The ability for NPs and PAs to prescribe weight loss medications varies by state:

Independent Practice States (34 states + DC as of 2025):In states like California, New York, Washington, Arizona, and Connecticut, experienced nurse practitioners can prescribe independently without physician oversight. This has significantly expanded access to telehealth weight loss care.

Collaborative Practice States:States like Texas, Florida, Georgia, and Pennsylvania require NPs and PAs to work under a physician collaboration or supervisory agreement. This doesn’t mean the physician must be present during your telehealth visit, but there must be an established professional relationship.

Important note: Georgia recently passed legislation (effective July 2024) allowing NPs and PAs to prescribe Schedule II controlled substances with physician delegation—a sign that scope of practice is gradually expanding even in traditionally restrictive states.

At Klarity Health, we work only with appropriately licensed and credentialed providers who meet your state’s requirements, so you can feel confident about the legitimacy of your prescriber.

What to Expect: The Telehealth Weight Loss Journey

Initial Consultation

A legitimate telehealth evaluation for weight loss medication isn’t a quick questionnaire—it’s a comprehensive medical assessment conducted via video conference. Here’s what your provider will cover:

Medical History Review:

• Current height and weight (you may be asked to verify with photos or during the video visit)
• Medical conditions, especially thyroid issues, gallbladder disease, pancreatitis, or gastrointestinal disorders
• Family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Current medications and allergies
• Previous weight loss attempts and lifestyle factors

Eligibility Assessment:Your provider will determine if you meet clinical criteria for GLP-1 therapy:

• BMI ≥ 30 (obesity), OR
• BMI ≥ 27 with weight-related health conditions like type 2 diabetes, high blood pressure, or high cholesterol

Risk Discussion:Reputable providers will discuss:

• Common side effects (nausea, vomiting, diarrhea, constipation)
• Serious but rare risks (pancreatitis, gallbladder problems, thyroid tumors in animal studies)
• Contraindications (pregnancy, personal or family history of certain cancers)
• The importance of lifestyle modifications alongside medication

Treatment Plan:If appropriate, your provider will:

• Prescribe the medication electronically to your pharmacy of choice
• Provide injection training resources
• Schedule follow-up appointments
• Discuss diet and exercise expectations

Ongoing Monitoring

Weight loss medication isn’t a one-and-done prescription. Responsible telehealth care includes:

Regular Follow-Ups:

• Initial check-in within 2-4 weeks to assess tolerance
• Follow-ups every 1-3 months to monitor progress, adjust dosage, and assess for side effects
• Some states legally require specific follow-up intervals (Florida: every 3 months; Virginia: within 30 days of starting)

Lab Monitoring:Depending on your health status, providers may request periodic blood work including:

• Comprehensive metabolic panel (kidney and liver function)
• Lipid panel
• Hemoglobin A1C (if diabetic or pre-diabetic)
• Thyroid function tests

Dose Titration:GLP-1 medications typically start at a low dose and gradually increase every 4 weeks to minimize side effects and optimize results. Your provider will guide this process based on your tolerance and weight loss response.

The Three Main Telehealth-Prescribed Weight Loss Medications

Wegovy (Semaglutide 2.4mg)

FDA Status: Approved specifically for chronic weight management in adults with obesity or overweight with weight-related conditions.

How It Works: Once-weekly injection that mimics GLP-1, a hormone that regulates appetite and blood sugar. Slows stomach emptying and increases feelings of fullness.

Typical Results: Clinical trials showed average weight loss of 15-17% of body weight over 68 weeks when combined with lifestyle modifications.

Telehealth Considerations: Most straightforward to prescribe via telehealth since it’s FDA-approved for weight loss. No ‘off-label’ documentation needed.

Supply: Initial prescriptions typically for 4 weeks (to assess tolerance), then 1-3 month supplies once dose is stable.

Ozempic (Semaglutide 0.5-1mg)

FDA Status: Approved for type 2 diabetes, but frequently prescribed off-label for weight loss.

How It Works: Same active ingredient as Wegovy but in lower doses. Once-weekly injection.

Typical Results: Similar weight loss results to Wegovy, though officially studied for diabetes management.

Telehealth Considerations: Providers must document the off-label rationale and obtain informed consent. Legal to prescribe via telehealth, but requires clear medical justification.

Important: Should not be combined with Wegovy (same ingredient). Not appropriate for patients without diabetes unless they meet obesity treatment criteria.

Mounjaro (Tirzepatide) / Zepbound

FDA Status: Mounjaro is approved for type 2 diabetes; Zepbound is the brand name for obesity treatment (approved November 2023).

How It Works: Dual-action medication that mimics both GLP-1 and GIP hormones. Once-weekly injection.

Typical Results: Clinical trials showed average weight loss of 15-21% of body weight—slightly higher than semaglutide alone.

Telehealth Considerations: The obesity-specific formulation (Zepbound) is now available, making telehealth prescribing straightforward when patients meet criteria.

Red Flags: How to Identify Questionable Telehealth Services

The popularity of GLP-1 medications has unfortunately attracted some less-than-scrupulous operators. Protect yourself by watching for these warning signs:

Guaranteed Prescriptions Without Evaluation

Any service promising you’ll ‘definitely get a prescription’ without a thorough medical screening is cutting corners. Legitimate providers assess eligibility and may determine these medications aren’t appropriate for you.

Compounded or ‘Generic’ Versions

In May 2025, the FDA ended the emergency allowance for compounded semaglutide, effectively banning most compounded weight loss versions. Legitimate providers prescribe FDA-approved brand medications from licensed U.S. pharmacies. Be extremely cautious of:

• ‘Compounded semaglutide’ or ‘custom formulations’
• Medications shipped from overseas
• Prices that seem too good to be true

No Follow-Up or Monitoring

If a service gives you a prescription and doesn’t schedule follow-up appointments or check in about side effects, that’s a major red flag. Safe prescribing requires ongoing monitoring.

Unclear Provider Credentials

You should always know:

• Your provider’s full name and credentials (MD, DO, NP, PA)
• What state they’re licensed in
• How to contact them with questions

If a platform is vague about who will be prescribing your medication, look elsewhere.

Skipping Risk Discussions

Responsible providers discuss:

• Common and serious side effects
• Contraindications and who shouldn’t take these medications
• The importance of lifestyle changes
• What to do if you experience concerning symptoms

If your consultation feels rushed or doesn’t cover these topics, the provider isn’t meeting the standard of care.

How Klarity Health Ensures Safe, Compliant Telehealth Care

At Klarity Health, we’ve designed our telehealth weight loss program around both clinical excellence and regulatory compliance:

Comprehensive Evaluations: Every patient completes a detailed health questionnaire and participates in a live video consultation with a licensed provider before any prescription is issued.

State-Specific Compliance: Our providers are licensed in the states where they practice, and we adhere to each state’s specific requirements—whether that’s coordinating initial in-person exams or ensuring proper follow-up intervals.

Transparent Pricing: We believe you should know exactly what you’re paying. We accept both insurance and offer cash-pay options with clear upfront pricing—no hidden fees or surprise charges.

Provider Availability: Our platform makes it easy to schedule follow-up appointments and message your provider with questions. We’re committed to ongoing care, not just one-time prescriptions.

FDA-Approved Medications Only: We prescribe only FDA-approved brand medications dispensed through licensed U.S. pharmacies. We don’t offer compounded versions or workarounds.

Holistic Approach: We recognize that medication is just one tool. Our providers work with you on sustainable lifestyle changes, including nutrition guidance and activity recommendations.

Insurance Coverage and Costs

Insurance Coverage

Coverage for weight loss medications varies significantly:

Medicare: As of 2025, traditional Medicare does not cover weight loss medications (though coverage for obesity counseling was expanded). Some Medicare Advantage plans do offer coverage.

Private Insurance: Coverage is expanding but inconsistent. Some plans cover Wegovy specifically for weight loss, while others only cover Ozempic for diabetes. Prior authorization is typically required.

Medicaid: Varies by state. Some state Medicaid programs cover weight loss medications, particularly when patients have obesity-related health conditions.

Cash-Pay Options

For patients without coverage:

Retail Prices:

• Wegovy: $1,300-$1,600 per month
• Ozempic: $900-$1,200 per month
• Mounjaro/Zepbound: $1,000-$1,400 per month

Manufacturer Savings Programs:Novo Nordisk (Wegovy/Ozempic) and Eli Lilly (Mounjaro/Zepbound) offer savings cards that can significantly reduce costs for eligible patients—sometimes to as low as $25 per month, depending on insurance status.

Telehealth Platform Fees:Most telehealth services charge consultation fees ranging from $49-$199 for initial visits and $29-$99 for follow-ups. At Klarity Health, we’re transparent about our consultation fees and can help you explore all available discount programs.

Comparison: Telehealth vs. Traditional In-Person Care for Weight Loss

Both approaches can deliver high-quality care—the best choice depends on your preferences, location, and your state’s specific requirements.

Looking Ahead: The Future of Telehealth Weight Loss Treatment

The regulatory landscape for telehealth continues to evolve in patient-friendly directions:

Federal Developments:

• The TREATS Act, reintroduced in October 2025, would make permanent certain telehealth prescribing flexibilities (primarily affecting controlled substances, but signaling broader support for telemedicine).
• The DEA is expected to extend or replace its temporary telehealth rules when they expire December 31, 2025—most experts anticipate continued flexibility rather than rollback.

State Trends:

• More states are moving toward full practice authority for nurse practitioners (34 states + DC as of 2025), which expands the provider pool for telehealth services.
• States are increasingly recognizing that requiring in-person visits for weight management creates barriers without improving outcomes, leading to more telehealth-friendly policies.

Clinical Innovations:

• New GLP-1 and combination medications are in development, offering more options.
• Integration of remote monitoring tools (smart scales, continuous glucose monitors) with telehealth platforms will enable even better ongoing care.

The trajectory is clear: telehealth for weight loss medication is not only here to stay—it’s becoming the preferred model for many patients and providers.

Frequently Asked Questions

Do I need to have an in-person visit before getting a prescription through telehealth?

It depends on your state. About two-thirds of states allow you to establish a patient-provider relationship via video consultation alone. However, states like Texas, Georgia, New Jersey, and several others require an initial in-person physical examination. Your telehealth provider will inform you of your state’s requirements and can often help coordinate any required in-person components.

Can a nurse practitioner prescribe weight loss medication through telehealth?

Yes, in all states nurse practitioners can prescribe GLP-1 medications, though the level of autonomy varies. In 34 states plus DC, experienced NPs can prescribe independently. In other states, they work under a collaborative agreement with a physician. Either way, NPs are fully qualified to manage weight loss medication therapy.

How long does a telehealth consultation for weight loss medication take?

Initial consultations typically last 30-45 minutes and cover your complete medical history, current health status, weight loss goals, and treatment options. Follow-up visits are usually shorter, around 15-20 minutes, focusing on progress, side effects, and dose adjustments.

Is it safe to get weight loss medication without seeing a doctor in person?

When done properly, yes. Studies have shown that telehealth delivers comparable quality of care to in-person visits for many conditions, including obesity management. The key is ensuring your provider conducts a thorough evaluation, discusses risks and benefits, and provides ongoing monitoring. Reputable telehealth services meet the same standards of care as traditional practices.

What if I experience side effects—can my telehealth provider help?

Absolutely. Your telehealth provider should be accessible for questions between scheduled visits. Most platforms offer secure messaging, and many provide phone or video consultations if you’re experiencing concerning symptoms. If you have a medical emergency, you should always call 911 or go to the nearest emergency room, just as you would with traditional care.

Will my insurance cover telehealth appointments for weight loss medication?

Most insurance plans cover telehealth consultations at the same rate as in-person visits, especially since the pandemic. However, coverage for the medications themselves varies significantly by plan. Your telehealth provider’s billing team can help verify your specific coverage before you begin treatment.

How quickly can I get started with telehealth weight loss treatment?

With most telehealth platforms, you can often schedule an initial consultation within 1-3 days. If approved for medication, your prescription can be sent electronically to your pharmacy the same day. In states requiring an initial in-person exam, there may be a brief delay while that component is arranged, but many patients can start treatment within a week.

Can I use telehealth if I live in a rural area?

Yes—in fact, this is one of telehealth’s greatest benefits. As long as you have reliable internet access for video consultations, you can access specialized weight loss care even if you live hours from the nearest obesity medicine specialist. Your medication can be sent to any pharmacy convenient to you.

Taking the Next Step: Starting Your Telehealth Weight Loss Journey

If you’re considering GLP-1 medications for weight loss, telehealth offers a convenient, accessible path to evidence-based treatment. The key is choosing a provider that prioritizes your safety, follows all applicable regulations, and provides comprehensive ongoing care—not just a quick prescription.

At Klarity Health, we’ve helped thousands of patients achieve meaningful, sustainable weight loss through our telehealth platform. Our providers take the time to understand your unique health situation, explain your options clearly, and support you throughout your journey.

Ready to explore whether telehealth weight loss treatment is right for you? Visit Klarity Health to complete a brief assessment and schedule a consultation with one of our licensed providers. With transparent pricing, insurance and cash-pay options, and providers available across multiple states, we make it simple to get the care you need—on your schedule, from the comfort of your home.

Remember: successful weight loss is about more than just medication. It’s about finding a healthcare partner who supports your goals, monitors your progress, and helps you build sustainable healthy habits. Telehealth can deliver all of that—and with today’s regulatory framework, it’s never been more accessible.

Research Currency Statement

Verified as of: December 17, 2025

DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.

States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of Dec 2025)

Sources newer than 2024: 15 of 18 sources (most sources are 2024–2025; older sources used only for baseline context)

⚠️ Flagged for follow-up: Federal telehealth rules for controlled substances are temporary (set to expire 12/31/2025) – an additional extension or new rule is expected. State laws are constantly evolving; watch for any changes in 2026 (e.g., pending NP practice authority bills in states like PA & MS, potential federal legislation like the TREATS Act). Also, FDA oversight on compounded GLP-1 medications tightened in 2025 – ensure compliance with current FDA guidance.

References

1. DEA and HHS Extend Telemedicine Flexibilities through 2025 – U.S. Drug Enforcement Administration, November 15, 2024. www.dea.gov

2. COVID-era telehealth prescribing extended – Axios, November 18, 2024. www.axios.com

3. DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025 – McDermott Will & Emery, November 18, 2024. www.mwe.com

4. Changing Regulatory and Reimbursement Landscape for Weight Loss Drugs – Goodwin Procter LLP, March 27, 2024. www.goodwinlaw.com

5. Know Your State’s Laws Around Semaglutide – Nextech, April 11, 2025. www.nextech.com

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid